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ABSTRACT 
 
Introduction 
This study aimed to examine e-cigarette user reasons for 
use, changes in their nicotine concentrations, and factors associated 
with changes in their chosen nicotine concentrations. 
Methods 
Data was from a convenience sample of 788 adult e-
cigarette users recruited in Mississippi, examining user 
demographics, current/history of use, and their perceptions. 396 
(34.64%) participants submitted a survey. Forty participants were 
excluded. The final sample was 356 for analyses. 
Results 
Participants had a mean e-cigarette time of use of about 24 
months, a mean current nicotine concentration level of 7.767 
mg/ml, and a mean initial nicotine concentration level of 8.851 
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mg/ml. About 56% were using their e-cigarettes for a harm 
reduction reason. Participants had a mean decrease of 1.084 mg/ml 
of their self-selected nicotine concentration (t=-1.747, p=0.082). 
Both linear regression models significantly explained the variance 
in the self-selected nicotine change score. 
Conclusions 
 Participants reported a decrease in selected nicotine 
concentration. Total time of e-cigarette use was a significant 
predictor within the two linear regression models on the self-
selected nicotine concentration change score, where increases in 
time of use were associated with greater decreases in the nicotine 
concentration change score. Vapers utilizing the e-cigarettes for 
harm reductions reasons had a greater decrease in the nicotine 
concentration change score than vapers using their e-cigarette for 
non-harm reduction reasons. Our findings reflect the existing 
literature and suggests that vapers will decrease their nicotine. Our 
study highlights the importance for additional research around 
changes in self-selected nicotine concentrations, and the use of e-
cigarettes for harm reduction or smoking cessation purposes. 
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CHAPTER 1 
INTRODUCTION 
 
 Of the more than 4,000 chemicals in tobacco, nicotine is thought to be the major reasons 
for tobacco dependence. The United States (U.S.) Centers for Disease Control and Prevention 
(CDC) reports that tobacco use is associated with over 480,000 deaths each year across the U.S., 
making it the largest cause of preventable mortality.1–3 While smoking prevalence has steadily 
decreased in the U.S. since 2005 from 20.9% of adults to 15.1% of adults, about 36.5 million 
adults, in 2015, there is still room for improvement.2 The decline in smoking prevalence is 
expected to continue as 68% of smokers indicated they wanted to quit smoking entirely in a 2015 
CDC survey.2 
The U.S. Food and Drug Administration (FDA) has approved two categories of smoking 
cessation pharmacotherapies: nicotine replacement therapy (NRT), and non-nicotine 
medications.4 NRT medications cover drugs intended to manage nicotine withdrawal side effects 
by providing controlled doses of nicotine. NRT can be found in different forms, including 
nicotine patches, nicotine lozenges, or nicotine gum. While non-nicotine cessation medications 
act on neurotransmitters in an effort to safeguard patients from the same side effects.4 Non-
nicotine medications include Chantix and Zyban.4 
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Chantix has been shown to have the greatest positive impact on cessation, among FDA 
approved cessation methods. Garrison et al. found that Chantix had success rates ranging from 
21.9% to 34.6% in various studies.5 Zyban, nicotine lozenges, and nicotine patches have been 
shown to have success rates of 16.8%-23.1%, 19.9%, and 17.7% respectively.6,7 However, 
smoking cessation clinical trials usually report greater rates of cessation due to the controlled 
environments they can provide or encourage, with actual success rates around 10% lower than 
reported.8 In addition to methods approved by the FDA, there are other approaches smokers use 
to aid in their quit attempts. 
Electronic cigarettes (e-cigarettes) use has increased at an alarming rate since their 
introduction in the U.S. in 2007. Originally developed by pharmacist Hon Lik, e-cigarettes 
commonly use a battery powered heating element to vaporize and deliver an aerosolized nicotine 
solution to be inhaled by the user.9–13 E-cigarettes offer a unique nicotine delivery mechanism 
which has encouraged the public to develop a widespread belief that e-cigarettes have potential 
to aid in smoking cessation.10,11,14–20 Rahman et al. explored this belief, reporting about an 18% 
cessation rate at the six-month follow up.15 This success rate is similar to that of NRTs, and 
Zyban, which are currently approved by the FDA for use in tobacco cessation.6,7 In addition, 
Nutt et al. conducted a relative harm analysis concluding e-cigarettes were 96% less harmful 
than conventional cigarettes (CC) when evaluating the potential harm to their users and 
bystanders.21  E-cigarette users have also reported the belief that e-cigarettes may inhibit nicotine 
cessation, while previous literature has reported they can cause side effects, and expose 
individuals to various chemicals at levels higher than recommended by the U.S. Environmental 
Protection Agency.8,9,11,16,22,23 
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Previous research has explored the characteristics of use among electronic cigarette users, 
and the reasons behind these characteristics: showing over 80% of electronic cigarette users are 
using their devices with smoking cessation as their main reason for use.17 Electronic cigarette 
users themselves have proposed that electronic cigarettes can help users quit by allowing them to 
reduce their e-cigarette nicotine concentration over time.16,18,23 Soule et al. reported e-cigarette 
users agreed that tapering down their nicotine concentration helped them quit tobacco.23 Current 
literature has not shown any connections between e-cigarette users’ reasons for using e-cigarettes 
and their chosen nicotine concentrations. More research is needed to inform the public and 
policy makers on the trends around the use of e-cigarettes and how their use can affect public 
health.  
This study utilized the Health Belief Model as the theoretical framework; concepts 
including, perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
cues to action, and self-efficacy were used to represent portions of an individual’s intent to 
complete or initiate an action or behavior.24–29 These concepts are complex in nature, initially 
being influenced by various factors of a person’s demographic background that affect how each 
individual values each of the constructs.24,26 Due to the complex nature of smoking cessation and 
e-cigarette use, subjective norms was used to account for the impact of each individuals’ social 
influences.30 
This study aimed to answer the following questions to provide evidence to policymakers, 
and researchers regarding e-cigarettes and smoking cessation. What are the reasons for use 
among electronic cigarette users? Do electronic cigarette users change their nicotine 
concentrations to help with smoking cessation? Which factors serve as predictors of change in 
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current electronic cigarette users’ chosen nicotine concentrations in their electronic cigarette 
liquid? 
The aims of this study were modified, upon completion of the first round of data 
collection, to answer the following questions to provide evidence to policymakers, and 
researchers regarding e-cigarettes and smoking cessation. What are the reasons for use among 
electronic cigarette users? Do electronic cigarette users change their nicotine concentrations? 
Which factors are associated with change in electronic cigarette users’ chosen nicotine 
concentrations in their electronic cigarette liquid? 
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CHAPTER 2 
LITERATURE REVIEW 
 
Food and Drug Administration’s Recent Announcement on Tobacco Regulations 
In July of 2017, the United States (U.S.) Food and Drug Administration (FDA) released 
an announcement detailing a shift of their regulations on tobacco and related products.31 The 
FDA detailed its main goals as protecting children from smoking and reducing morbidity and 
mortality associated with tobacco utilization.31 A major component of this announcement 
described aims to begin a discussion on reducing nicotine levels in cigarettes to non-addictive 
levels.31 The FDA also intends to limit the introduction of new tobacco and electronic nicotine 
delivery system (ENDS) products by establishing end dates for new products in August 2021 for 
combustible tobacco products and August 2022 for ENDS products.31 A 2015 study by 
Grebenstein et al. demonstrated using lab rats, that lowering the level of nicotine in cigarettes 
would lead to a brief increase in the amount of cigarettes utilized but would result in lower usage 
levels subsequently.32 Benowitz and Henningfield discussed current studies around lowering 
nicotine concentrations in cigarettes with the general consensus that lowering nicotine levels 
could reduce nicotine exposure while not increasing cigarette consumption or could reduce 
nicotine dependence.33 Sofuoglu and LeSage reviewed current literature on reducing cigarette 
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nicotine levels to at or below the reinforcement threshold, showing that the plan could work, but 
should be carried out over a longer period of time.34 They concluded that additional research was 
needed to better inform policy recommendations.34  
The FDA’s plan could potentially reshape the current tobacco epidemic through a series 
of changes, by encouraging current smokers to quit, and preventing future generations from 
picking up smoking. By preventing the introduction of new products and lowering the nicotine 
levels to non-addictive levels, the U.S. could see large movements of smokers switching to 
alternative products to either continue or taper off their addictions. Under these new time 
restrictions for the introduction of tobacco and ENDS products, continued research needs to be 
carried out to monitor all related changes and trends. ENDS research has continually increased 
since their introduction however, understanding the individual and societal impacts of these 
products is paramount from a public health standpoint. This study intends to collect data on 
ENDS use to better inform policy creation. 
Tobacco and Nicotine Addiction 
 The U.S. Centers for Disease Control and Prevention (CDC) reports that tobacco use is 
associated with over 480,000 deaths each year across the U.S., making it the largest cause of 
preventable mortality.1–3 Smoking prevalence has steadily been on the decline in the U.S. since 
2005, from 20.9% of adults to 15.1% of adults in 2015, about 36.5 million adults.2 The decline in 
smoking prevalence is expected to continue as 68% of smokers indicated they wanted to quit 
smoking entirely, in a 2015 CDC survey.2 
Of the more than 4000 chemicals in tobacco, nicotine is thought to be the major reason 
for tobacco dependence.6,35 When nicotine is absorbed in the human body, it acts on hormones 
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and neurotransmitters including dopamine, serotonin, norepinephrine, acetylcholine, vasopressin, 
and beta-endorphins.6,36 Nicotine affects the central nervous system by increasing alertness, 
improving memory, improving concentration, and decreasing anxiety.6,36 These effects provide a 
temporary calming and euphoric high, producing a strong addiction to nicotine in a short 
timeframe.6,36  
Due to the nature of the addiction, tobacco dependence is considered a chronic relapsing 
disease.6,36 Achieving smoking cessation is as difficult as quitting alcohol, cocaine, or heroin, 
with multiple relapses expected throughout the process.6,35 Smokers looking to quit have 
pharmacologic, and/or behavioral options to help them achieve success and combat some 
withdrawal symptoms they may experience, including increased irritability or anxiety, new or 
worsening depression, weight gain, increased appetite, cravings to keep using tobacco, trouble 
sleeping, or difficulty thinking.4,35 If successful in their cessation attempt, former tobacco users 
will also benefit from lower risks for cardiovascular disease, respiratory disease, and various 
types of cancer.35 
Food and Drug Administration Approved Smoking Cessation Methods and Their Effectiveness 
The FDA has multiple approved pharmacologic agents to aid in smoking cessation; in 
addition, there are other interventions that smokers may find helpful in their quit attempts, such 
as counseling, cognitive behavioral therapy or other behavioral interventions.4 There are two 
categories of pharmacologic cessation aids, nicotine replacement therapies (NRT) and non-
nicotine medications.4,35 Over-the-counter NRTs include nicotine patches (also available with a 
prescription), nicotine gum, and nicotine lozenges. Nicotine inhalers, and nicotine sprays are 
available with a prescription.4,35 Non-nicotine pharmacologic cessation agents include Chantix 
(varenicline tartrate), and Zyban (bupropion hydrochloride), both of which are available with a 
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prescription.4,35 Behavioral therapies have also been shown to improve success rates associated 
with quitting tobacco products.6,35,36 
Chantix has been shown to have the greatest positive impact on cessation, among FDA 
approved cessation methods. Garrison et al. found that Chantix had success rates ranging from 
21.9% to 34.6% in various studies.5 Zyban, nicotine lozenges, and nicotine patches have been 
shown to have success rates of 16.8%-23.1%, 19.9%, and 17.7% respectively.6,7 Smoking 
cessation clinical trials usually report greater rates of cessation due to the controlled 
environments they can provide or encourage, with actual success rates being around 10% lower 
than reported.8 In addition to cessation methods approved by the FDA, there are other 
approaches smokers use to aid in their quit attempts. Recent trends have shown a widespread 
belief that electronic cigarettes (e-cigarettes) have potential to aid in smoking cessation.10,11,14–20 
Simmons et al. conducted focus groups with current and former smokers on their beliefs 
surrounding e-cigarettes with their participants reporting they greatly benefited from their use, as 
a cessation aid, in addition to seeing improvements in their health.18 A recent study conducted by 
Ayers et al. reported that the most prevalent reason for ENDS use, found in their Twitter content 
analysis, was quitting combustible tobacco products (43%, 95% CI (39-48)).19  
Electronic Cigarette History and Regulations 
 E-cigarettes, or ENDS, are battery-operated devices designed to be used to inhale an 
aerosol solution typically containing nicotine. The history of electronic cigarettes can be traced 
back to 1962, when Herbert Gilbert initially developed a tobacco-less smoking device that would 
produce a non-nicotine vapor to be inhaled by the user.37 Gilbert’s precursor to modern e-
cigarettes never achieved commercial success and failed to enter the market.37 Modern e-
cigarettes were developed by Chinese pharmacist Hon Lik and received the first patent on his 
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device in China during 2003.9–13,38 International and U.S. patents came later in 2007.9,39 As a 
previous pack a day smoker, Hon Lik developed ENDS to help himself and others achieve 
tobacco cessation after his father passed away from smoking-related lung cancer.13  
 In the U.S., the most recent regulations regarding e-cigarettes and related products came 
from the FDA in 2016.40 The FDA moved e-cigarette products under their tobacco regulations.40 
This move set the minimum age to purchase e-cigarettes to 18 across the U.S. and allows the 
FDA to regulate the, “manufacture, import, packaging, labeling, advertising, promotion, sale, 
and distribution,”40 of e-cigarette products.40 Some states, like Hawaii in 2016, have opted to 
increase the minimum age of purchase and/or ban e-cigarette usage in public places.41 Outside 
the U.S., countries have taken varying approaches to e-cigarettes. Some countries such as 
Australia, Brazil, Canada, Mexico, Panama, Singapore, and Switzerland have opted to outright 
ban e-cigarettes.9 However, the United Kingdom’s (U.K.) Medicines and Healthcare Regulatory 
Agency announced a plan to regulate e-cigarettes as smoking cessation medication in 2014.12 
The U.K. offers e-cigarettes in the same fashion they do as NRT products, in that they are 
covered under their national healthcare system as a smoking cessation medication.12 
Electronic Cigarette Terminology, Components, and Fluid 
 E-cigarette users, or ‘vapers’ as they prefer to be called, can purchase a variety of ENDS, 
including cig-alike, e-cigarettes, electronic pipes, electronic cigars, disposable vapes, hookah 
pens, and vape mods (highly customizable e-cigarettes).18,40,42 Whichever version of ENDS a 
vaper may use, they do share a few common qualities.  Each ENDS utilizes a battery or multiple 
batteries to power a heating element, referred to as an atomizer, which vaporizes the fluid 
contained in the tank/reservoir to produce a cloud of vapor for the user to inhale.9,39,40,42 Each 
part of the more customizable e-cigarettes can be interchanged to create different setups. The 
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original cig-alike e-cigarettes utilized an airflow sensor to initiate vaporization while newer 
models use a button clicked and held by its user.9 The fluid vaporized by the ENDS usually 
contains some mixture of propylene glycol , glycerin, nicotine, natural/artificial flavorings, and 
occasionally water.9,38,40,42–44  
Bahtnagar et al. reported as of 2014 that there were 466 brands, and 7,764 unique flavors 
of e-juice in e-cigarettes.9 These numbers are expected to increase as the ENDS industry and 
consumer base continues to grow. Some e-cigarettes allow the user to adjust the voltage/wattage 
(VW) the device will produce. Higher VW increases the temperature the coil in the atomizer will 
reach, which can increase the volume of e-cigarette juice vaporized, adjust the flavor profile. 
Decreasing the VW can increase battery life or adjust the flavor. The nicotine concentrations in 
e-cigarette fluid ranges from 0 mg/ml to ~50 mg/ml.18,23 Hajek et al. reported that the most 
popular nicotine concentrations utilized by vapers was around 18 mg/ml.11 In a more recent 
study, Soule et al. reported 8 mg/ml being the most popular e-cigarette nicotine concentration 
used by vapers.23  
Electronic Cigarette Safety and Potential for Dependence 
Current literature reports e-cigarettes are at least 95% less harmful than convention 
cigarettes (CC) and the public would benefit from smokers switching from CC to e-
cigarettes.9,14,21,45,46 For example, Nutt et al. conducted a relative harm analysis concluding e-
cigarettes were 96% less harmful than CC when evaluating the potential harm to their users and 
bystanders.21 While less harmful than CC, e-cigarettes are not safe and can produce hazardous 
substance that users inhale.9,11,21,45 Chen et al. reported e-cigarettes exposed users to average 
levels of acrolein and propylene glycol were higher than recommended by the U.S. 
Environmental Protection Agency’s guidelines.45 In addition, emissions maximum exposure 
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levels of diethylene glycol, and cadmium were at levels higher than the Environmental 
Protection Agency’s guidelines.45 Hajek et al. evaluated a study completed in Japan, suggesting 
that e-cigarettes are exposing users to formaldehyde at levels 5 to 15 times that of CC.14 A later 
study published in the New England Journal of Medicine followed up on the previous claim 
finding negligible formaldehyde levels at lower e-cigarette power settings, lower VW.14 
Formaldehyde was detected at higher power levels or in e-cigarettes with low fluid, however 
vapers are able to instantly detect this phenomenon due to a harsh and acrid taste, prompting 
them to refill their e-cigarettes or turn down the power.14 
Bhatnagar et al. reported vapers may also be exposed to different particulates, including 
tin, iron, nickel, chromium, ceramics, plastics, rubber, or foams when using e-cigarettes.9 The 
metals could come from the type of metal the coil in the atomizer is made. Some e-cigarettes can 
control their power output in terms of VW, while some can also control the exact temperature to 
which they heat specific metals. To provide an example of this, the Reuleaux RX200 can control 
temperatures of the coil if it is made from titanium, stainless steel, or nickel in addition to 
controlling the VW it produces.47  
In a 2014 study, Polosa et al. reported common adverse events related to e-cigarette use 
at 4, 8, 12, and 24-week follow-ups. Adverse reactions included, throat/mouth irritation (35.6%), 
dry throat/mouth (28.9%), headache (26.7%), and dry cough (22.2%) at the 4-week follow-up.8 
The prevalence of these adverse events generally declined over time, with 10.5%, 18.4%, 21.2%, 
and 5.3% reporting the same events at the 24-week follow-up, respectively.8 Other adverse 
events included dizziness, nausea, sore throat, palpitations, and a choking sensation at lower 
prevalence rates.8,48 
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The early versions of disposable e-cigarettes released in Poland, the U.K., and the U.S. 
had varying efficiencies at vaporizing the nicotine they contained.38 Goniewicz and colleagues 
studied 16 types of e-cigarettes in their ability to vaporize the nicotine they contained, showing 
the e-cigarettes studied vaporized between 21% to 85% of the nicotine they contained after 300 
puffs.38 Goniewicz et al. also showed that the labeled nicotine concentrations in some brands 
may be significantly different from their actual nicotine concentrations.38 With the advancement 
of the e-cigarette industry, improved standards have been set up as well as the improvement of 
the various e-cigarette types. The ability and efficiency of an e-cigarette to vaporize its nicotine 
may affect vaper dependence.43 The same applies to CC and NRT in their delivery methods and 
levels of nicotine exposure.43 Etter and Eissenberg conducted a study to evaluate dependence 
levels of e-cigarette, nicotine gum (NRT), and CC users. They found that CC are by far the most 
addictive delivery method with e-cigarettes being about addictive or potentially less addictive 
than nicotine gum.43 Goldenson et al. reported on high school student use of e-cigarettes, finding 
that higher levels of e-cigarette nicotine concentrations increased the odds for participants to still 
be vaping at the 6 month follow up.49 
Electronic Cigarette Populations Statistics and Economics 
 The U.S. has seen rapid economic growth in the e-cigarette market, with sales having 
almost doubled each year since 2008.9,10,50 In 2014, the CDC reported that about 3.7% of 
American adults currently used e-cigarette, with 12.6% of adults having ever tried them.2 The 
CDC reported on the prevalence of electronic cigarette use for 2014 showing men (4.1%) have a 
higher rate of use than women (3.4%).51 Adults age 18-24 (5.1%), and age 25-44 (4.7%) have 
higher rates than adults age 45-64 (3.4%) and 65+ (1.4%).51 Non-Hispanic whites (4.6%), and 
American Indians/Alaskan Natives (10.7%, 95% CI [5.3, 20.4]) use e-cigarettes at a significantly 
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greater rate than non-Hispanic black (1.8%), non-Hispanic Asian (1.5%), and Hispanic (2.1%) 
subgroups.51 Current smokers (15.9%), recent former smokers (22.0%), and long term former 
smokers (2.3%) have higher rates of current use of e-cigarettes when compared to those who 
never smoked cigarettes (0.4%).51  
 Xu et al. reported that the sales of electronic cigarettes reached $12 million in 2011, $22 
million in 2012, and $28 million in the second quarter of 2013 in the U.S.10 Correspondingly, the 
CDC reported e-cigarettes sales increased about 320% for disposable e-cigarettes, 72% for 
starter kits, and 82% for cartridges between 2012 and 2013.50 Wells Fargo has predicted global 
sales for e-cigarettes could grow to $10 billion by 2017.9 With the increasing market and 
consumers of e-cigarettes, e-cigarettes have become a focus point for scientific inquiry. Xu 
reported on the growth of e-cigarette related articles in PubMed from less than 100 in 2012, to 
more than 200 in 2013, and 800 in 2014.10,52 We conducted our own search of PubMed with the 
search terms ‘electronic cigarette’, ‘e-cigarette’, ‘e-cig’, ‘electronic vaping device’, ‘personal 
vaping device’, ‘electronic nicotine’, ‘electronic nicotine delivery system’, ‘electronic hookah’, 
‘electronic cigar’, ‘cig-alike’ or ‘vaper,’ in the titles of articles. Our PubMed search occurred at 
the beginning of October 2017 and found 1,041 search results. 
Electronic Cigarettes Reasons for Use and Surrounding Opinions 
 Various reasons for use of e-cigarettes have been provided by vapers, smokers, ex-
smokers, and non-smokers. Tobacco cessation is a well discussed reason for e-cigarette use, with 
many respondents reporting they decrease their e-cigarette fluid nicotine concentration over 
time.10,16–19,23,44,53,54 However, more research is still needed to examine the safety and 
effectiveness of e-cigarettes as a cessation aid and their overall public health impact before 
policy and health recommendations can be made. 
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Tobacco reduction usually involves dual-use of e-cigarettes and some form of tobacco, 
like cigarettes or cigarillos, but is a hazard to the user’s health due to the continued use of 
tobacco.16,17,23,44 While this method is a matter of concern, Carpenter et al. and Hammond et al. 
have reported NRT has been used with the same strategy.55,56 Tobacco reduction usually uses 
nicotine products to reduce or eliminate side effects of tobacco/nicotine withdrawal, if the user 
has to go an extended period without their tobacco product, like at work, or on commercial 
airline flights. Tobacco replacement or tobacco relapse prevention employs e-cigarettes as a 
substitute for tobacco products and is another common reason for use reported by vapers.16 
Tobacco replacement or relapse prevention is another reason for use common with NRT.16,55  
Some vapers use e-cigarettes to circumvent public smoking laws as most smoking bans 
don’t include e-cigarettes, another strategy associated with NRT products as well.19,23,44,55 This is 
not the case on commercial airlines, as the U.S. Transportation Security Administration and 
individual airline companies, like Delta Airlines, do not allow e-cigarette use onboard 
commercial flights and e-cigarettes must be carried in carry-on baggage.57,58 Recreational use has 
also been cited as a reason to use e-cigarettes, this is a cause for concern that will require 
additional research on how to curb this phenomenon.23,44,45,53  
 Respondents from various studies have shared their opinions related to the perceived 
benefits associated with e-cigarettes. Perceived benefits for e-cigarettes include a sense of 
belongingness in the vaping community, allowing vapers to keep their social surroundings even 
if their peers use tobacco, recreating reinforcing habits associated with smoking (personal cues, 
hand to mouth, social, drinking, etc.), reducing their withdrawal symptoms with nicotine like 
NRT, decreasing/tapering their nicotine concentrations to quit at their own pace, and the variety 
of available flavors which enable them to stay away from tobacco and menthol flavors.16–19,23,46 
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Studies have also reported that some respondents believe e-cigarettes are less harmful and 
healthier than CC in addition to other forms of tobacco products.10,16–18,20,23,44,59,60 Etter reported 
participants who were using e-cigarettes to quit smoking, believed they were “better for (their) 
health than tobacco.”44 Opposing to the reported perceived benefits, vapers have also reported 
perceived risks associated with e-cigarettes, in that they could hinder a smoker from attaining 
cessation by potentially maintaining nicotine addiction, the persistence of a craving for tobacco, 
exposing e-cigarette users to carcinogens, and other unknown long-term adverse health 
effects.16,23  
Electronic Cigarettes and Smoking Cessation 
 E-cigarettes have been promoted as a smoking cessation aid in marketing and advertising 
campaigns by their manufacturers, and distributors.10,12,16,61 Grana et al. reported 64% of e-
cigarette advertisements contained claims related to smoking cessation.61 In comparison, 
Wackowski et al. reported 84% of vapers use e-cigarettes as a cessation method.17 Rahman et al. 
developed a meta-analysis of six studies detailing the effect of e-cigarettes on smoking cessation 
and reported an 18% cessation rate by the six-month follow up.15 This success rate is similar to 
that of NRTs, and Zyban.6,7 Polosa et al. conducted a pilot study in 2011 and a clinical trial in 
2014 examining CC use reduction associated with e-cigarette use.8,48 The pilot study reported 
approximately 81% of participants sustained a 50% or greater reduction in CC use while using e-
cigarettes at 24-weeks follow-up with one-third having achieved complete cessation.48 Their 
clinical trial reported 86% of participants sustained a 50% or greater reduction in CC use at 24-
weeks follow-up and about 47% achieved complete cessation.8 Polosa et al. concluded as a 
tobacco harm reduction strategy, e-cigarettes are a realistic and promising method.8 However, 
both studies started with small samples (n=40, n=50, respectively) and lost participants by the 
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24-week follow up.8,48 The pilot study lost 13 participants while the clinical trial lost 12 
participants.8,48 
A systematic review examined four e-cigarette clinical trials, and concluded that nicotine-
containing e-cigarettes are not an efficacious method for smoking cessation.12 The review states 
that non-nicotine placebo e-cigarettes may be useful as a substitute of the sensory and behavioral 
aspects of smoking.12 One recent systematic review and meta-analysis conducted by El Dib et al. 
of e-cigarette randomized control trials concluded that there is very limited evidence on the 
impact or efficacy of e-cigarettes in smoking cessation.62 The authors reported these trials did not 
adhere to a standard definition of smoking cessation with each study employing a different 
definition and stressed that future e-cigarette trials need to be well-designed and biochemically 
validated outcomes need to be measured.62 Future studies in e-cigarette research should employ a 
standard definition of smoking cessation and trials need to take into account the opinions and 
experiences of current vapers and vapers who successfully terminated their tobacco addiction. 
Electronic Cigarette Gradual Reduction and Personalized Nicotine Concentration Strategies 
 Research on reasons to use e-cigarettes have reported users believe that e-cigarettes can 
help combat a smoker’s addiction to nicotine or tobacco through a gradual reduction in their e-
cigarette fluid nicotine concentration. This strategy has been proposed as a means to end 
cigarette smoking at a policy level, by implementing legal limits on the nicotine contained in 
CC.31,32,34,63,64 Benowitz et al. conducted a study on tapering nicotine concentrations in CC and 
found the participants experienced reduced adverse effects with 25% of their participants (n=20) 
achieving cessation even though they didn’t enter the study to quit.64,65 Benowitz et al. employed 
nicotine tapering from cigarettes containing 12mg of nicotine down to 1mg of nicotine over a 10 
week period showing that nicotine reduction strategies using e-cigarettes could be beneficial to 
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their users.64,65 Beginning a smoker’s cessation attempt on a standardized level of nicotine may 
not produce ideal outcomes for every individual. Every smoker varies in their use of CC or other 
tobacco products which might necessitate a more customized cessation plan. Rose et al. has 
proposed a personalized smoking cessation strategy tailored to each individual.66 This strategy 
could be useful as cigarettes have been known to have different levels of nicotine, and not every 
cessation method works for every person, as shown by the success rates between 16% and 35% 
of NRT, Zyban, and Chantix.5–7,67 
Soule et al. surveyed vapers on their reasons for using e-cigarettes, finding that vapers 
primarily use e-cigarettes for smoking cessation but there are many other reasons for their use.23 
In this study, the perceived benefit of e-cigarettes to taper or reduce nicotine concentrations over 
time was rated an average of 5.49 on a scale from 1 to 7.23 Other qualitative studies have also 
reported that vapers decrease their nicotine concentration in their e-liquids over time. For 
example, Simmons et al. conducted a series of focus groups on vapers perceptions and intentions 
for future use.18 A theme obtained from the groups was that users were intentionally trying to 
reduce the amount of nicotine in the e-cigarettes they used, and reported success in doing so 
obtaining some of the lowest nicotine concentrations for the brands they used.18 Camenga et al. 
conducted 18 focus groups with an emergent theme of ‘Methods for Smoking Cessation’ 
containing a prevalent belief that ‘e-cigarette users could gradually reduce or “wean” nicotine 
dosage,’ and that smokers may benefit from this elongated process.16 However, little information 
is available regarding the extent of vapers’ chosen nicotine concentration changes over time and 
what characteristics of individual users affect the choices made regarding vapers’ chosen 
nicotine concentrations over time. 
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Theoretical Framework 
 The Health Belief Model (HBM) has become one of the most widely used behavioral 
frameworks, since its introduction in the early 1950s.24–26,29 This model has been employed 
extensively in studying personal health behavior and behavioral changes as it provides an 
explanation of how an individual’s beliefs affect their choice to engage in or change a health 
behavior.24,26 There are six central concepts within the HBM including perceived susceptibility, 
perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy.24–29 
These concepts each represent portions of an individual’s intent to complete or initiate an action 
or behavior. Perceived susceptibility and perceived severity are interlinked in perceived threat 
with susceptibility referring to an individual’s perceived risk to a negative effect and severity 
describing the belief of how serious the negative effect is.24,26,29 Vapers can identify their risk for 
a side effect from vaping and how serious they believe that side effect is. Perceived benefits are 
the positive outcomes of the action or behavior, while perceived barriers are the costs and 
negative predispositions associated with the action or behavior.24,26,29 Vapers could see less side 
effects and more control over their addiction using e-cigarettes when compared to CC or they 
could have a negative view on e-cigarettes. Cues to action involve different methods to get a 
person ready to carry out the action or behavior with self-efficacy being the person’s belief in 
their ability to carry out the action or behavior.24,26,29 A vaper’s support system, might be 
inclined to provide a cue to action if they support the use of an e-cigarette for CC cessation. A 
vaper’s internal motivation to change a behavior can affect their actions taken to change that 
behavior, vapers with more motivation to quit smoking CC, may be more inclined to change 
their nicotine concentrations faster. 
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These central concepts of the HBM are influenced by a combination or the individuals’ 
socioeconomic and demographic characteristics, in that a person’s background will affect how 
they value and perceive each of the constructs.24,26 The HBM does not have an emphasis on 
social norms and the influence of an individual’s peers.29 Due to the complex nature of smoking 
cessation and e-cigarette use, social influences in the form of subjective norms will also need to 
be considered. Subjective norms cover the normative beliefs of people around the individual in 
question in addition to the individuals value of the referred person, the closer a peer is to the 
individual, the more importance or weight the individual might place on the peer’s opinion.29,30 
Intentions of smokers, ex-smokers, and vapers can be described with the HBM, with each 
of the six concepts represented in tobacco or e-cigarette use. Mohammadi et al. and Reisi et al. 
have conducted studies utilizing the HBM to predict the actions of smokers under the age of 18, 
showing that perceived susceptibility, perceived benefits, perceived barriers, and self-efficacy 
are all related to tobacco use.27,28 Reisi et al. reported that smokers and non-smokers have 
significant differences in perceived susceptibility (p=0.03), perceived benefits (p=0.01), self-
efficacy (p<0.001), and cues to action (p=0.007).27 Mohammadi et al. conducted a study of the 
HBM related to smoking and reported self-efficacy, and cues to action as significant predictors 
of smoking behavior.28 This study will utilize the HBM with the addition of subjective norms as 
a theoretical framework to identify predictors of change in vapers’ chosen nicotine 
concentrations in their e-cigarette liquid. A diagram of out theoretical framework can be found in 
Appendix B. 
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Implications for Research 
E-cigarette use has increased at alarming rates since their introduction in the U.S.2 
Researchers and their respondents have expressed concern regarding the use of e-cigarettes as a 
potential gateway to CC or other tobacco products. As with Hon Lik’s original intention for e-
cigarettes, research has shown that a majority (84%) of vapers use e-cigarettes for smoking 
cessation purposes.17 However, more research on the reasons for e-cigarette use and the extent of 
e-cigarette use is needed to better understand their short-term and long-term impact on public 
health. Since the FDA’s July 2017 announcement on plans to discuss nicotine levels in CC, 
smokers may be more motivated to begin to lower their nicotine levels at a more controlled rate 
and could be drawn to NRT, or to e-cigarettes. This potential ‘migration’ of smokers to NRT and 
e-cigarettes accentuates the importance for more research on the patterns of use with these 
products and research to help inform the development of personalized smoking cessation 
strategies tailored to each individual. 
Original Objectives 
In this study, we aim to: 
 Determine the reasons for electronic cigarette use amongst current electronic cigarette 
users. 
 Describe changes in current electronic cigarette users’ chosen nicotine concentrations in 
their electronic cigarette liquid over a six-month period. 
 Identify predictors of change in current electronic cigarette users’ chosen nicotine 
concentrations in their electronic cigarette liquid. 
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Modified Objectives 
In this study, we aimed to: 
 Determine the reasons for electronic cigarette use amongst current electronic cigarette 
users. 
 Describe changes in current electronic cigarette users’ chosen nicotine concentrations in 
their electronic cigarette liquid. 
 Identify factors associated with change in current electronic cigarette users’ chosen 
nicotine concentrations in their electronic cigarette liquid. 
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CHAPTER 3 
METHODS 
 
Hypotheses 
 Based on a review of the literature in smoking cessation and electronic cigarette use, we 
hypothesized that (1) the majority of vapers are using electronic cigarettes with smoking 
cessation as their main goal;17 (2) vapers will decrease their chosen concentration of  
nicotine ;16,18,23 (3) self-efficacy and cues to action will be the strongest factors associated with 
each vapers’ change in their chosen nicotine concentrations over a six-month period.28,67 
Study Design 
 This study employed a cross-sectional survey, recruiting a convenient sample of 
electronic cigarette users. Participants are referred to as ‘vapers’ in this study, current literature 
shows they prefer to be identified with this term.18 Electronic surveys were utilized to collect 
data on the following elements: reasons for e-cigarette use, future e-cigarette use intentions, 
patterns of use, and constructs specified in the theoretical framework within electronic cigarette 
users at two time points during the study. The surveys also contained questions aimed at 
examining vapers’ chosen nicotine concentrations, smoking cessation strategies, duration of use, 
frequency of use, history of cigarette use, history of other tobacco use, and future intentions of 
using electronic cigarettes. In addition, vapers’ socio-demographic information was collected. 
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To track each vaper, their email address was acquired to distribute the survey. However, 
vaper date of birth, address, name, or other personally identifiable information was not collected 
to protect the respondents’ identities. All collected personally identifiable information was 
maintained in a password protected laptop, or in a secure and undisclosed locked location. Only 
research team members have access to personally identifiable information. Confidentiality was 
further protected separating personally identifiable information from vapers’ responses into a 
separate document. At the end of the study, all personally identifiable information will be deleted 
along with the email file to further protect the identity of vapers. Deidentified data will be 
maintained on secure files thereafter. This study has been approved by the University of 
Mississippi’s Institutional Review Board. 
Sample Population and Recruitment Strategy 
This study utilized a convenience sampling strategy, producing a non-randomized 
sample. All results are reported as observed correlations as we cannot infer causality due to the 
sampling design. Recruitment was carried out in person by a research team member in central, 
and northern Mississippi vape shops. We gathered the majority of vapers in Oxford, MS to 
reduce any travel costs associated with the study. After participants were made aware of their 
rights as research participants, they were asked to give written consent, in the form of their email 
address, in order to participate in the study. Vapers’ emails were used to link their responses on 
the survey with their consent forms. An example consent form can be found in Appendix C.  
Necessary sample size was calculated using G*Power, finding that 165 participants will 
be needed to meet the analytical needs of this study at the second survey.68 However, the 
literature shows that around 80% of users are using electronic cigarettes with cessation as a 
reason and about 60% of the initial sample remained in studies till completion. With these 
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adjustments, we proposed to recruit a minimum of 350 participants to maintain enough 
participants for statistical analyses at the time of the second survey.  
The inclusion criteria for this study are individuals who are 18 years of age or older, and 
currently use an e-cigarette at the time of recruitment. Before being asked to participate in the 
survey, each person was provided with information on their rights as a research participant and 
asked to complete a consent form. Participants were excluded if they are under 18 years of age, 
report that they have never used an electronic cigarette before, did not currently use an electronic 
cigarette, or did not complete the survey through the demographic section. The emphasis on age 
is due to current Mississippi and federal legislation on e-cigarette use, setting the minimum age 
to purchase e-cigarette products to 18. Objective 3 utilized an additional exclusion criterion in 
that participants had to complete the questions related to this study’s theoretical model. The 
inclusion and exclusion criteria were examined using the first three (3) questions of the initial 
survey. To show appreciation for their participation and to increase response rate, respondents 
were notified that they would receive a $5 Amazon e-gift card sent via email after completing the 
survey. 
Data Collection 
 Data collection was carried out via Qualtrics. The initial survey was emailed to the 
participant within 48 hours after the completion of their consent form. The survey was 
distributed from a University of Mississippi email address to each participant’s provided email 
address. To boost the response rate, participants received two email reminders at one week and 
two weeks after the distribution email, if we did not have a response from their email address. In 
addition, the gift card reward for survey participation was expected to help increase the survey’s 
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response rate. All data was stored on Qualtrics until it was transferred to a researcher’s secure 
laptop. 
Survey Development 
The survey was developed in Qualtrics, under a license held by the University of 
Mississippi. The first question contained information on who to contact if the participant had any 
questions or trouble on/with the survey. The initial survey utilized its second, third, and fourth 
questions to filter out any participants who do not meet the inclusion criteria. This was carried 
out in a specific order to protect the identities of those participants who do not qualify to 
participate. The second question asked the age of the participant to verify they were of a legal 
age to use electronic cigarettes. The third question asked if the participant currently used 
electronic cigarettes as the survey was intended to assess current users of electronic cigarettes. 
The last inclusion/exclusion question requested the participants email address to link their 
responses to their consent forms. 
Demographic questions were developed based on the CDC’s National Youth Tobacco 
Survey and National Adult Tobacco Survey.69,70 Electronic cigarette and conventional cigarette 
history of use questions were developed based on questions in the National Youth Tobacco 
Survey and National Adult Tobacco Survey, specifically questions attempting to identify the 
duration of lifetime use and recent use the specified products.69,70 The CDC defines a smoker as 
someone who has smoked at least one CC in the last month and at least 100 CCs over their 
lifetime.70 A question from the National Health Interview Survey was utilized to ask about 
tobacco cigarette use.71 The National Adult Tobacco Survey was used to determine if 
respondents meet the CDC definition of a smoker.70 Questions regarding predictors of vaper’s 
chosen nicotine concentrations in their e-cigarettes liquid were developed bases on the 
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theoretical framework of this study, a study by Kelley Rhoads, a study by Coe et al., and a study 
by Soule et al.23,72,73  
This survey contained 53 questions, of these nine were required questions: three were for 
the inclusion criteria, three asked about nicotine concentrations, two were on time frames 
associated with nicotine concentrations, and one asked about their reason for using e-cigarettes. 
This survey utilized skip logic to reduce the amount of questions a participant would have to 
complete when the questions were not applicable to the participant. If a participant had never 
smoked CC, then the survey would skip to the first question after the CC questions. There were 
some questions contained within the survey intended to inform future research questions or act as 
back up analyses in the event of a high sample attrition rate. These questions pertained to 
financial costs associated with e-cigarettes, volume of e-cigarette liquid use, vaper flavor 
preferences, and vapers beliefs on flavors impact on their tobacco quit attempts. The 
questionnaire was pilot tested with a small sample to check for face validity before deploying it 
to our main participants. An example survey can be found in Appendix C. 
Study Variable Operationalization 
 The theoretical framework and current literature in smoking cessation and e-cigarettes 
informed the operationalization of variables contained in the survey. Sociodemographic variables 
of age (≥18 years), sex, race, ethnicity, and educational attainment were measured the survey. 
 The survey examined reasons for use using two primary questions and some additional 
follow up to confirm the participant uses their electronic cigarette as described. Participants were 
asked if they are using e-cigarettes for the following reasons: to circumvent smoking bans, to 
reduce how much they smoke CC, to switch their CC for their e-cigarette, to replace their CC for 
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their e-cigarette and reduce their nicotine, to quit another form of tobacco, to control their 
appetite/for weight loss, for fun, for a buzz/high, or other, with the option to insert their own 
answer on a follow up question. 
Participants were asked their currently used nicotine concentrations in milligrams per 
milliliter (mg/ml), since this is the standard unit used in e-cigarettes. In addition, they were also 
be asked the nicotine concentration they used when they first started using their e-cigarette. 
Nicotine concentration will be referred to as nicotine level in the survey to allow the participants 
to see terminology they are familiar with. 
A brief history of use in e-cigarettes and CC was determined through a series of questions 
designed to determine the duration and severity of use, in addition to two questions to determine 
if the smoker meets the CDC definition of a smoker. The history section asked participants about 
usage of e-cigarettes and CC among their family and friends. Peer use of either nicotine delivery 
system, served as a basis for the subjective norms in the theoretical construct. Participants’ 
beliefs were looked at using a series of statements where the participant is asked to identify if 
they strongly agree to strongly disagree. Theses belief statements are listed in Appendix A and 
were utilized to represent the constructs from the theoretical model. Some of these statements 
were positively coded while others were negatively coded to examine the consistency of a 
respondent’s answers. 
Data Analysis 
 Descriptive statistics were conducted on the vapers’ sociodemographic characteristics, e-
cigarette characteristics of use, and CC characteristics of use, including frequencies and 
percentages. The e-cigarette characteristics included their reasons for use, future intentions for e-
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cigarette use, their initial nicotine concentration, and their current nicotine concentration. Using 
the matched nicotine concentrations of each participant, a paired samples t-test was utilized to 
examine the differences between vapers’ initial nicotine concentrations and their current nicotine 
concentrations. Two linear regression models were created to identify factors associated with 
changes in vapers’ chosen nicotine concentrations. The first model contained the vapers’ e-
cigarette characteristics of use and their sociodemographic characteristics. The second model 
expanded from the first to include the factors from our theoretical model. 
An Alpha of 0.05 was used to determine statistical significance. All t values are reported 
as two-tailed tests. Statistical analyses were conducted in IBM’s SPSS 25.0, under a license held 
by The University of Mississippi.74 Data collected in Qualtrics was downloaded in to an Excel 
file and then transferred in to SPSS. 
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CHAPTER 4 
RESULTS 
 
Total Sample and Exclusions 
Upon completion of the survey collection, consent was received from a total of 788 
individuals, of which 396 (34.64%) submitted a survey via Qualtrics. Thirty-three participants 
were excluded for not completing the survey through the demographics section. Two participants 
responded to the survey twice, their second responses were removed. Four participants were 
excluded due to their reported current nicotine concentration level not reflecting a mg/ml format. 
One participant was excluded due to an error in reported total time of e-cigarette use in months. 
The final sample was 356 for analyses. In addition, 14 participants were excluded from the linear 
regression models for not completing the questions related to this study’s theoretical model. 
Sample Characteristics 
The sample was primarily male, white/Caucasian, non-Hispanic/Latino/a, and had started 
or completed their education past a high school degree. The average age of the study sample was 
23.8 years. Participants had a mean e-cigarette time of use of about 24 months, a mean current 
nicotine concentration level of 7.767 mg/ml, and a mean initial nicotine concentration level of 
8.851 mg/ml. The majority of participants planned to keep their nicotine concentrations the same 
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in the next 6 months, planned not to quit using their e-cigarette in the next 6 months, primarily 
used tank mod e-cigarettes, and used e-cigarettes to replace their CC use. Participants had a 
mean time of cigarette use of about 8 years and had a mean of about 3.2 quit attempts. Quitting 
‘cold turkey’ or by their willpower alone was the predominant method of cessation utilized by 
participants with 185 (58.9%) having reported they attempted this method. Three-hundred and 
sixteen participants reported having ever used a cigarette, with 256 reporting they have used at 
least 100 cigarettes. Ninety-two participants met the CDC definition of a smoker with at least 
100 cigarettes used in their lifetime and at least one used in last month. Table 1 presents the 
descriptives statistics of participants’ sociodemographic information. Table 2 presents the 
descriptives statistics of participants’ e-cigarette characteristics of use. Table 3 presents the 
descriptives statistics of participants’ CC characteristics of use. 
Difference in Self-Selected Nicotine Concentration from Initial to Current E-Cigarette Use 
Participants reported a mean initial nicotine concentration of 8.851 mg/ml and a mean 
current nicotine concentration of 7.767. Participants had a mean decrease of 1.084 mg/ml of their 
self-selected nicotine concentration in their e-cigarette nicotine solution from their initial use of 
e-cigarettes to their current use of e-cigarettes; however, this decrease was not statistically 
significant (t=-1.747, p=0.082). See Table 4 for the results of the paired samples t-test regarding 
the change in self-selected nicotine concentration from initial to current use of e-cigarettes. 
Factors Associated with Change in Self-Selected Nicotine Concentration from Initial to Current 
E-Cigarette Use 
Main reason for e-cigarette use were collapsed from nine different options to three 
including, harm reduction (reduce cigarette consumption, replace cigarettes, replace cigarette and 
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reduce nicotine, and replace other form of tobacco), non-harm reduction (to circumvent smoking 
bans, for weight loss/control appetite, for fun, and for buzz/high), and other. Main type of e-
cigarette used were collapsed from five option to two options including, customizable e-
cigarettes (tank-mod e-cigarettes and drip mod e-cigarettes) and non-customizable e-cigarettes 
(cig-alikes, vape pens, and e-hookahs). Table 5 reports results of linear regression model 
examining e-cigarette use characteristics, CC use characteristics, and sociodemographic 
characteristics. The model explained 19.6% of the variance in the self-selected nicotine 
concentration change score. Collinearity statistics were within an appropriate range. E-cigarette 
time of use (months) was a significant predictor, with each one month increase in the time of e-
cigarette use there was a decrease in nicotine concentration change score of 0.099 mg/ml. There 
was a significant difference between individuals using e-cigarettes for a non-harm reduction 
reason and individuals using e-cigarettes for a harm reduction reason. Vapers using e-cigarettes 
for non-harm reduction reasons had an increase of 3.273 mg/ml on the change score when 
compared vapers using e-cigarettes harm reduction reasons. 
  Table 6 reports results of the second linear regression model, which explained 23.2% of 
the variance in the self-selected nicotine concentration change score. Collinearity statistics were 
within an appropriate range. Model 2 includes all variables used in model 1 with the addition of 
the factors associated with change from our theoretical model. E-cigarette time of use (months) 
was a significant predictor, with each one month increase in the time of e-cigarette use there was 
a decrease in the nicotine concentration change score of 0.095 mg/ml. There was a significant 
difference between individuals using e-cigarettes for a non-harm reduction reason and 
individuals using e-cigarettes for a harm reduction reason. Vapers using e-cigarettes for non-
harm reduction reasons had an increase of 3.087 mg/ml on the change score when compared 
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vapers using e-cigarettes harm reduction reasons. Self-efficacy was a significant predictor, with 
each one unit increase in the self-efficacy score, there was a decrease in the nicotine change 
score of 0.340 mg/ml. Perceived severity was a significant predictor in the model with each one 
unit increase in the perceived severity score, there was an increase in the nicotine change score 
of 0.239 mg/ml. 
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CHAPTER 5 
DISCUSSION 
 
 In our sample of 356 adult vapers, about 56% were using their e-cigarettes for a harm 
reduction reason of reducing cigarettes, replacing cigarettes, replacing cigarettes and reducing 
nicotine concentration, or replacing another form of tobacco. The obtained sample for this study 
reflects the population of e-cigarette users in the U.S. as reported by the CDC.37 The sample had 
a mean and median age of about 24 years, which matched the CDC’s report showing the 
majority of users were age 18-44 years of age.37 Participants reported a decrease in selected 
nicotine concentration; while this was not a statistically significant finding it does show that 
vapers are decreasing their self-selected nicotine concentrations. 
Total time of e-cigarette use was a significant predictor within the two linear regression 
models on the self-selected nicotine concentration change score, where increases in time of use 
were associated with greater decreases in their nicotine concentration change score. Vapers 
utilizing the e-cigarettes for harm reductions reasons had a greater decrease in their nicotine 
concentration change score than vapers using their e-cigarette for non-harm reduction reasons. 
Individuals seeking harm reduction or smoking cessation may be more motivated to decrease 
their nicotine concentrations and consequentially their nicotine consumption and dependence.  
34 
 
 Existing literature has discussed the perception of vapers that e-cigarettes can be utilized 
for smoking or tobacco cessation by replacing their tobacco product with an e-cigarette and 
changing their nicotine level over time to reach complete nicotine cessation. Our findings reflect 
the existing literature and suggests that vapers will decrease their nicotine concentrations to a 
lower level the longer they use their e-cigarette.  
Self-efficacy was statistically significantly associated with decreases in the nicotine 
concentration change score. within our second regression model. Individuals who believe they 
can achieve smoking or nicotine cessation may be more motivated to decrease their self-selected 
nicotine concentrations. Perceived severity was statistically significantly associated with increase 
on the nicotine concentration change score. This does not reflect our initial hypothesis on 
perceived severity as we expected individuals experiencing more side-effects associated with e-
cigarettes to have greater reductions in their nicotine concentrations. The remining factors 
included in the theoretical framework of this study were not statistically significantly associated 
with the changes in nicotine concentrations for our participants. The scores for perceived 
barriers, and subjective norms were not significant predictors of the self-selected nicotine 
concentration change score however, they were associated with a decrease in nicotine 
concentration. While we pulled from existing surveys and literature, we did not use a validated 
questionnaire, and we used more general questions around e-cigarettes instead of questions 
specifically aimed at informing the nicotine change score to determine if the questions were 
measuring what they intended to.  
To our knowledge this study is the first to examine changes in self-selected nicotine 
concentrations and factors associated with such changes, and our finding reflect current literature 
on the belief of vapers that they can reduce their nicotine concentrations.16–18,23 Our study 
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highlights the importance for additional research around changes in self-selected nicotine 
concentrations, and the use of e-cigarettes for harm reduction or smoking cessation purposes. 
Future studies should attempt to further understand the reasons and factors associated with 
change in vapers’ self-selected nicotine concentration scores to provide additional information to 
the public and policy makers. These studies should attempt to use validated measures to obtain a 
clearer view of each factor’s relationship with changes in vaper self-selected nicotine 
concentrations, specifically focusing on harm-reduction, self-efficacy, perceived barriers, and 
subjective norms. 
Current literature is showing changes in the e-cigarette population towards nicotine salts 
e-cigarettes, like JUULs which accounted for about 40% ($150 million) of e-cigarette sales in the 
fourth quarter of 2017.39 JUULs and similar devices (like Sourin e-cigarettes) utilize a different 
form of nicotine from traditional e-cigarettes, higher nicotine concentrations than traditional e-
cigarettes (35 mg/ml and 59 mg/ml), and have a striking appeal with a sleek, non-modifiable, 
closed system device that easier to use and maintain compared to tank mod or drip mod e-
cigarettes.39–41 Our survey obtained information on the types of e-cigarettes used and the self-
selected nicotine concentrations used by vapers. Vapers within our sample reported nicotine 
levels associated with nicotine salts e-cigarettes and 26.2% of our sample reported using a vape 
pen or cig-alike e-cigarette.  
Scott Gottlieb, the former FDA Commissioner, made a statement in early 2018 on the 
FDA’s intent to prevent the use of JUULs and other e-cigarettes by youth.42 This statement also 
provides information of the FDA’s plan considering the regulation of nicotine levels in cigarettes 
to minimally or non-addictive levels and suggests that e-cigarette may offer an alternative with 
potentially lower risk to adult smokers.42 In April of 2019, the FDA made a statement on a link 
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between e-cigarettes and seizures in youth and young adults, potentially associated with high 
levels of nicotine or the use of other substances.43 Continued research is necessary around the 
characteristics of the population using e-cigarettes, specifically around JUULs and similar 
devices for their unique characteristics, high nicotine concentrations, and higher potential for 
nicotine dependence in youth, young adults and, non-smokers. 
 This study has several limitations. First, since this is a cross-sectional observational 
study, we can observe correlations, but causation cannot be drawn from the data collected. There 
is also the potential for the participants to change their habits after the point of data collection. 
Second, we employed a survey as the main method of our data collection, there is the chance for 
socially desirable response bias as e-cigarettes and their use could be seen in a negative context 
by society or portions therein. There is a potential for response bias due the recall of each 
participant in addition to each participants’ honesty when responding to the surveys. Multiple 
response bias was controlled for using each participants’ email address, and two responses were 
excluded based on matching emails. Third, this study did not measure nicotine dependence in e-
cigarette users, and instead examine changes in their self-selected nicotine concentrations that 
current literature supports as a method of decreasing nicotine dependence. And fourth, this study 
measured the factors from our framework at the time of the survey to examine associations with 
previous change and may not accurately reflect the true associations between each construct 
within the framework and the self-selected nicotine change. 
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CHAPTER 6 
CONCLUSION 
 
 Existing literature around e-cigarettes seems to support their use for harm reduction 
purposes. Smokers and other tobacco users seeking to use e-cigarettes for smoking cessation or 
harm reduction may benefit from their use in decreasing their nicotine dependence or potentially 
reaching cessation. However, e-cigarettes are not safe and should not be utilized by individuals 
who do not already use another form of nicotine. Literature on e-cigarettes and smoking 
cessation is inconclusive, necessitating continued vigilance in understanding the current 
population utilizing them and any changes within the e-cigarette marketplace. The population 
using e-cigarettes is constantly changing with the development of new devices like the JUUL, 
and similar devices, which are appealing to the young adult and adolescent population and after 
each legislative change at the federal or state level as well. Future studies should attempt to 
disseminate more information on devices like the JUUL due to their higher nicotine 
concentrations, appeal to young adults and adolescents, and greater potential for dependence. 
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Tables 
Table 1. 
Descriptive Statistics of Sociodemographic Characteristics Among Survey Respondents 
Sociodemographic Characteristics n Mean (SD) Median Min Max 
Age 356 23.747 (8.962) 23.5 18.0 59.0 
 Frequency Percent 
Sex 
 Female 152 42.7% 
 Male 203 57.0% 
Race 
 Black/African American 21 5.9% 
 White/Caucasian 314 88.2% 
 Other 21 5.9% 
Hispanic or Latino/a 
 Not Hispanic or Latino/a 349 98.3% 
 Hispanic or Latino/a 6 1.7% 
Education 
 High School or Less 90 25.3% 
 More than High School 266 74.7% 
 
Table 2. 
Descriptive Statistics of E-Cigarette (E-Cig) Characteristics of Use Among Survey Respondents 
Vaper Characteristics of E-Cig Use n Mean (SD) Median Min Max 
E-cig Use (months) 356 23.331 (20.308) 18.0 0.0 126.0 
Initial Nicotine Level (mg/ml) 356 8.851 (9.515) 6.0 0.0 59.0 
Current Nicotine Level (mg/ml) 356 7.767 (11.368) 5 0.0 60.0 
 Frequency Percent 
Plans to Change Nicotine Level 
 Increase 5 1.4% 
 Keep Same 269 75.8% 
 Decrease 81 22.8% 
Plans to Quit E-Cig 
 Yes 19 5.4% 
 Maybe 120 33.8% 
 No 216 60.8% 
Type of E-cig Used Most 
 Cig-Alike 33 9.3% 
 Vape Pen 60 16.9% 
 E-Hookah 2 0.6% 
 Tank Mod 225 63.2% 
 Drip Mod 36 10.1% 
Main Reason for E-Cig Use 
 Reduce Cigarette Use 17 4.5% 
 Replace Cigarette 93 26.1% 
 Replace, and Reduce Nicotine Level 72 20.2% 
 Quit Non-Cigarette Tobacco 18 5.1% 
 Circumvent Smoking Ban 9 2.5% 
 Weight Loss/Control Appetite 12 3.4% 
 For Fun 61 17.1% 
 For a Buzz or High 52 14.6% 
 Other 22 6.2% 
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Table 3. 
Descriptive Statistics of Conventional Cigarette (CC) Characteristics of Use Among Survey Respondents 
Vaper Characteristics of CC Use n Mean (SD) Median Min Max 
Cigarette Use (years) 316 8.005 (8.132) 5.0 0.0 40.0 
Quit Attempts 309 3.201 (4.144) 2.0 0.0 25.0 
 Frequency Percent 
Cigarette Ever Use 
 Yes 316 89.5% 
 No 37 10.5% 
At Least One Cigarette in Last Month 
 Yes 117 37.1% 
 No 198 62.9% 
At Least 100 Cigarettes in Lifetime 
 Yes 256 81.0% 
 No 60 19.0% 
CDC Smoker 
 Yes 92 29.1% 
 No 224 70.9% 
Cessation Methods Used 
 Any (Yes) 205 65.3% 
 Nicotine Replacement Therapy (Yes) 87 27.7% 
 Chantix (Yes) 40 12.7% 
 Zyban (Yes) 5 1.6% 
 Behavioral Therapy/ Counseling (Yes) 7 2.2% 
 ‘Cold Turkey’/ Willpower Alone (Yes) 185 58.9% 
 
 
Table 4. 
Results of Paired Samples t-Test of Current Nicotine Concentration and Initial Nicotine Concentration 
Mean Nicotine Concentration Mean Difference (SD) 95% CI of Mean Difference p 
Initial (SD) Current (SD) Lower Upper 
8.851 (9.515) 7.767 (11.368) -1.084 (11.711) -2.305 0.136 0.082 
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Table 5. 
Results of Linear Regression Model Examining the Associations of Respondent Sociodemographic Characteristics, 
E-Cigarette (E-Cig) Use Characteristics, and Conventional Cigarette Use Characteristics on Current-Initial 
Nicotine Concentration Change Score 
Variable Regression Coefficient (Unstandardized) Regression 
Coefficient 
(Standardized
) 
p value 
Estimate SE 95% CI 
Constant 3.457 3.208 -2.854 9.769 - 0.282 
E-Cig Use Characteristics  
E-Cig Time (months) -0.099 0.031 -0.159 -0.039 -0.170 0.001 
Use Most Harm 
Reduction 
- - - - - - 
Non-Harm 
Reduction 
3.273 1.488 0.347 6.200 - 0.028 
Other 1.501 2.476 -3.370 6.371 - 0.545 
E-Cig Most  Customizable - - - - - - 
Non-
Customizable 
1.915 1.436 -0.910 4.739 - 0.183 
Conventional Cigarette Use Characteristics  
CDC Current 
Smoker 
No - - - - - - 
Yes 2.304 1.368 -0.387 4.995 - 0.093 
Cessation Any No - - - - - - 
Yes -2.392 1.401 -5.148 0.363 - 0.089 
Cigarette Time (years) -0.126 0.138 -0.397 0.144 -0.086 0.360 
Sociodemographic Characteristics  
Age (years) -0.111 0.117 -0.340 0.118 -0.086 0.342 
Sex Female - - - - - - 
Male 0.175 1.228 -2.241 2.591 - 0.887 
Race White/ 
Caucasian 
- - - - - - 
Black/ African 
American 
1.356 2.513 -3.587 6.299 - 0.590 
Other -1.978 2.432 -6.762 2.805 - 0.416 
Hispanic/ 
Latino/a 
Not Hispanic/ 
Latino/a 
- - - - - - 
Hispanic/ 
Latino/a 
5.001 4.480 -3.812 13.814 - 0.265 
Education High School or 
Less 
- - - - - - 
More than High 
School 
0.557 1.376 -2.150 3.264 - 0.686 
R2 = 0.196 | F = 6.133 (p<0.0001) 
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Table 6. 
Results of Linear Regression Model Examining the Associations of Respondent Sociodemographic Characteristics, 
E-Cigarette (E-Cig) Use Characteristics, Conventional Cigarette Use Characteristics,  
and Factors Associated with Change from Theoretical Model on Current-Initial Nicotine Concentration Change 
Score 
Variable Regression Coefficient (Unstandardized) Regression 
Coefficient 
(Standardized) 
p value 
Estimate SE 95% CI 
Constant 6.482 10.285 -13.754 26.717 - 0.529 
E-Cig Use Characteristics  
E-Cig Time (months) -0.095 0.031 -0.156 -0.035 -0.164 0.002 
Use Most Harm 
Reduction 
- - - - - - 
Non-Harm 
Reduction 
3.087 1.501 0.134 6.040 - 0.041 
Other 2.000 2.477 -2.874 6.874 - 0.420 
E-Cig Most Customizable - - - - - - 
Non-
Customizable 
1.236 1.486 -1.688 4.161 - 0.406 
Conventional Cigarette Use Characteristics  
CDC Current 
Smoker 
No - - - - - - 
Yes 1.821 1.363 -0.861 4.503 - 0.183 
Cessation Any No - - - - - - 
Yes -0.098 0.139 -4.997 0.553 - 0.116 
Cigarette Time (years) -0.092 0.140 -0.372 0.177 -0.068 0.484 
Socio-Demographic Characteristics  
Age (years) -0.108 0.119 -0.343 0.127 -0.084 0.368 
Sex Female - - - - - - 
Male 0.148 1.238 -2.287 2.583 - 0.905 
Race White/ 
Caucasian 
- - - - - - 
Black/ African 
American 
1.755 2.554 -3.269 6.780 - 0.492 
Other -1.197 2.453 -6.023 3.629 - 0.626 
Hispanic/ 
Latino/a 
Non-Hispanic/ 
Latino/a 
- - - - - - 
Hispanic/ 
Latino/a 
4.571 4.473 -4.228 13.370 - 0.308 
Education High School or 
Less 
- - - - - - 
More than High 
School 
0.307 1.383 -2.414 3.027 - 0.825 
Factors Associated with Change  
Perceived Severity 0.239 0.115 0.014 0.465 0.125 0.038 
Perceived Susceptibility 0.347 0.227 -0.099 0.793 0.103 0.127 
Perceived Benefits 0.057 0.170 -0.277 0.391 0.021 0.736 
Perceived Barriers -0.505 0.269 -1.034 0.024 -0.104 0.061 
Cues to Action 0.025 0.225 -0.419 0.469 0.006 0.912 
Self-Efficacy -0.340 0.139 -0.615 -0.066 -0.132 0.015 
Subjective Norms -0.182 0.179 -0.534 0.170 -0.062 0.309 
R2 = 0.232 | F = 2.176 (p=0.036) 
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APPENDIX A: Statements Utilized to Measure Theoretical Model of Health-Related 
Beliefs Regarding E-Cigarettes 
Factor Associated 
with Change 
Statements Utilized to Measure Theoretical Model of Health-Related  
Beliefs Regarding E-Cigarettes 
Perceived Severity I cough when using my electronic cigarette  
I get headaches when using my electronic cigarette  
My throat gets sore/dry when I use my electronic cigarette  
I am addicted to my electronic cigarette  
I can't leave my house without my electronic cigarette  
I have to use my electronic cigarette at work/school  
Perceived 
Susceptibility  
Electronic cigarettes are addictive  
I feel healthy using my electronic cigarette  
I crave using my electronic cigarette  
Electronic cigarettes are safe 
Perceived Benefit Electronic cigarettes are safer than tobacco cigarettes around my friends and family  
Electronic cigarettes are safer around my pets  
Electronic cigarettes can be used to quit smoking tobacco cigarettes  
Electronic cigarettes are safer than tobacco cigarettes  
I cough more using tobacco cigarettes than electronic cigarettes 
Perceived Barrier  I am saving money with my electronic cigarette  
Electronic cigarettes can be used in more places than tobacco cigarettes  
Cues to Action My friends and family encourage me to use my electronic cigarette  
My family wants me to stop using my electronic cigarette  
My friends want me to stop using my electronic cigarette  
Self-Efficacy I am able to taper down my nicotine level over time  
I want to stop using my electronic cigarette  
I believe I can stop using my electronic cigarette  
I don't want to stop using my electronic cigarette  
I believe my electronic cigarette will help me quit smoking tobacco cigarettes 
Subjective Norms Electronic cigarettes are socially accepted  
I think my friends approve of me using my electronic cigarette  
I think my family approves of me using my electronic cigarette  
My coworkers/fellow students don't mind me using my electronic cigarette 
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APPENDIX B: Theoretical Framework Model 24,26,29,30 
 
 
 
 
 
 
 
 
 
 
  
Perceived Severity 
How Vapers See the 
Severity of Side Effects 
Perceived Susceptibility 
Vapers Perceived Risk 
for a Side Effect 
Perceived Benefits 
Less Cigarette Use or 
Less Side Effects 
Compared to Tobacco 
Use 
Perceived Barriers 
Legal Restrictions or 
Financial Difficulty 
Cues to Action 
Outside Support to Quit 
Smoking 
Self-Efficacy 
How Driven and Self-
Motivated a Vaper is to 
Perform and Action 
Perceived Threat 
Action or 
Change in Behavior 
Changes in Nicotine 
Level 
Subjective Norms 
What a Vaper’s Peers 
Think About Vaping 
(Perceived Benefits) 
minus (-) 
(Perceived Barriers) 
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APPENDIX C: Research Consent Form 
 
Consent to Participate in Research 
  
Study Title: Two Surveys: Questions on Electronic Cigarette History of Use, Reasons for Use, 
and Patterns of Use 
 
Investigator      Faculty Sponsor 
David D. Allen III, B.A.    Yi Yang, MD, Ph.D. 
Department of Pharmacy Administration  Department of Pharmacy Administration  
223 Faser Hall      223 Faser Hall 
University of Mississippi    University of Mississippi 
University, MS 38677    University, MS 38677 
(330) 283-6224     (662) 915-1062 
ddallen@go.olemiss.edu    yiyang@olemiss.edu  
                             
The purpose of this study 
We want to know how and why you use your electronic cigarette and to see if there are any 
changes in the next six (6) months. 
 
What you will do for this study 
You will be completing two surveys. One in the next few days, and one in six (6) months 
1. You must be at least 18 years old to participate in this study. 
2. You must currently use an electronic cigarette product to participate in this research. 
3. You must have internet access, via a computer, tablet, or phone, to complete the survey. 
4. Your email address will be asked for at the bottom of this consent form. Your email 
address will allow us to connect your answers in the first survey to your answers in the 
second survey. 
a. Please provide an email you use and check on a regular basis. 
5. First Survey 
a. You will receive this survey within forty-eight (48) hours after completing this 
consent form. 
b. This survey should take you about fifteen (15) to twenty (20) minutes to 
complete. 
c. There are fifty-two (52) questions, and 2 information statements. 
i. These questions will ask you about your current and past electronic 
cigarette and conventional (tobacco) cigarette use. 
ii. There are five (5) questions asking for your demographic information 
(sex, race/ethnicity, age, and educational attainment). 
iii. You are only required to complete nine (9) questions. 
 Qualtrics will inform you if you missed a required question and 
will ask you to complete it before continuing. 
iv. While, you are only required to complete nine (9) of the fifty-two (52) 
questions, we encourage you to answer all the questions as this will best 
help out our study. 
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d. The first question will contain David D. Allen III’s contact information if you 
have any questions or issues with the survey. 
e. At the completion of this survey, you will receive $5.00 Amazon e-gift card in 
your email within ten (10) business days. 
6. Second Survey (Last Survey) 
a. You will receive an email reminding you that this survey is coming up within two 
weeks of you receiving it. 
b. You will receive this survey about six (6) months after completing the first 
survey. 
c. This survey should take you about ten (10) to fifteen (15) minutes to complete. 
d. This survey will contain less questions than the First Survey. 
e. At the completion of this survey, you will receive $5.00 Amazon e-gift card in 
your email within ten (10) business days. 
 
Time required for this study 
This study will take about twenty (20) minutes for the 1st survey, and fifteen (15) minutes for the 
2nd survey – for a total of thirty-five (35) minutes. 
 
Possible risks from your participation 
Answering survey questions on your electronic cigarette and convention (tobacco) cigarette use 
may be stressful. Please see the Confidentiality section for information on how we minimize the 
risk of a breach of confidentiality. 
 
Benefits from your participation 
You should not expect benefits from participating in this study. However, you might experience 
satisfaction from contributing to the scientific knowledge on and around electronic cigarettes. 
Also, answering the survey questions might make you more aware of habits you’d like to 
change, sometimes this can help lead to improved habits. 
 
Incentives 
You will receive a one (1) $5.00 Amazon e-gift card via email within ten (10) business days after 
completing each survey, for a total of two (2) Amazon e-gift cards worth a total of $10.00. 
 
Confidentiality 
Your email address(es), phone number (where applicable), and responses will remain in 
password protected electronic files on a password protected laptop. Only research team members 
will have access to your email address(es), phone number, and responses. We will protect 
confidentiality by coding and then separating your email address(es), and phone number from 
your responses into a separate password protected document. At the end of the study, your email 
address(es), and phone number will be deleted along with the password protected file to further 
protect your identity. 
 
Members of the Institutional Review Board (IRB) – the committee responsible for reviewing the 
ethics of, approving, and monitoring all research with humans – have authority to access all 
records. However, the IRB will request identifiers only when necessary. We will not release 
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identifiable results of the study to anyone else without your written consent unless required by 
law. 
 
Right to Withdraw 
You do not have to volunteer for this study, and there is no penalty if you refuse.  If you start the 
study and decide that you do not want to finish, just close your web browser.  Whether or not 
you participate or withdraw will not affect your current or future relationship with the 
Department of Pharmacy Administration, or with the University, and it will not cause you to lose 
any benefits to which you are entitled.   
 
The researchers may stop your participation in the study without your consent and for any 
reason, such as protecting your safety or protecting the integrity of the research data.  If the 
researcher terminates your participation, any incentives will be prorated based on the amount of 
time you spent in the study. 
 
IRB Approval 
This study has been reviewed and approved by The University of Mississippi’s Institutional 
Review Board (IRB).  The IRB has determined that this study fulfills the human research subject 
protections obligations required by state and federal law and University policies.  If you have any 
questions or concerns regarding your rights as a research participant, please contact the IRB at 
(662) 915-7482 or irb@olemiss.edu. 
 
Please email, or call the primary researcher, David D. Allen III, if there is anything that is not 
clear or if you need more information. When all your questions have been answered, you can 
then decide if you want to be in the study or not. 
 
Statement of Consent 
I have read the above information. I have been given an unsigned copy of this form.  I have had 
an opportunity to ask questions, and I have received answers. I am at least 18 years old. I consent 
to participate in the study by providing my email address to receive the surveys. 
 
 
Email Address (Please print, in the field below) 
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Back-up Email Address or Telephone Number (Please print, in the field below) 
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APPENDIX D: Survey 
Electronic Cigarette History of Use, Reasons for Use, and Patterns of Use 
 
 
Start of Block: E-Cigarette Survey 
 
Q1  
Please Contact David Allen if you have any questions or issues on/with the survey. 
 
 
 David D. Allen III 
 (330) 283-6224 
 Ddallen@go.olemiss.edu 
 
 
 
 
 
Q2  
How old are you? (years) 
________________________________________________________________ 
 
Skip To: Q55 If How old are you? (years) < 18 
 
 
Q3 Do you currently use any of the following: electronic cigarette, vape pen, vape pipe, vape mod, or 
other vape product? 
o Yes  
o No  
 
Skip To: Q55 If Do you currently use any of the following: electronic cigarette, vape pen, vape pipe, vape mod, o... 
= No 
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Q4  
What is an e-mail address we can use to reach you? Your email will also be used to compare your 
answers between this survey and the next survey we send you. Please remember this is also the email you 
will receive your Amazon e-gift card at upon completion of this survey. 
________________________________________________________________ 
 
Skip To: End of Survey If What is an e-mail address we can use to reach you? Your email will also be used to 
compare your a... Is Empty 
 
 
 
Q5 How long have you used an electronic cigarette or related product? (months) 
________________________________________________________________ 
 
 
 
Q6 Are you planning to stop using your electronic cigarette in the next six (6) months? 
o Yes  
o Maybe  
o No  
 
 
 
 
Q7 What nicotine level e-liquid are you currently using in your electronic cigarette? (in milligrams per 
milliliter, mg/ml | example: 6) 
________________________________________________________________ 
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Q8 Have you changed the nicotine level in your e-liquid since you started vaping? 
o Yes  
o No  
 
Skip To: Q12 If Have you changed the nicotine level in your e-liquid since you started vaping? = No 
 
 
 
Q9 When you first started using your electronic cigarette, what nicotine level e-liquid were you using in 
your electronic cigarette? (in milligrams per milliliter, mg/ml | example: 6)  
________________________________________________________________ 
 
 
 
 
Q10 About how long has it been since you last changed your e-liquid nicotine level? (months) 
________________________________________________________________ 
 
 
 
 
Q11 Before you changed your nicotine level, what nicotine level e-liquid were you using in your 
electronic cigarette? (in milligrams per milliliter, mg/ml | example: 6)  
________________________________________________________________ 
 
 
 
Q12 Are you planning to change the nicotine level of the e-liquid you use in the next six (6) months? 
o Yes, increase  
o No, keep the same  
o Yes, decrease  
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Q13  
Approximately, how many milliliters (ml) of e-liquid have you used in the past month? (number of 
milliliters | ex: 120)  
________________________________________________________________ 
 
 
 
 
Q14 On average, about how much do you spend on e-liquid over a month? (dollars and cents, 00.00) 
________________________________________________________________ 
 
 
 
 
Q15 On average, about how much do you spend on replacement coil, cotton, wire, or other electronic 
cigarette parts over a month? (dollars and cents, 00.00 | please exclude the cost of e-liquid) 
________________________________________________________________ 
 
 
 
 
Q16 How many days do you use your electronic cigarette in an average month? (0 to 30) 
________________________________________________________________ 
 
 
 
 
Q17  
How many days did you crave using your electronic cigarette in the past month? (0 to 30) 
________________________________________________________________ 
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Q18 On average, how many times a day do you puff from your electronic cigarette? (puffs) 
________________________________________________________________ 
 
 
 
Q19  
What types of electronic cigarettes have you used? (please select all that apply) 
 Cig-alike (Blu, N-Joy, etc.)  
 Vape Pen  
 E-Pipe  
 E-Hookah  
 Vape Mod with a Tank Atomizer  
 Vape Mod with a Drip Atomizer  
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Q20  
Thinking about the list above, which type of electronic cigarette have you used the most? (please select 
only one) 
o Cig-alike (Blu, N-Joy, etc.)  
o Vape Pen  
o E-Pipe  
o E-Hookah  
o Vape Mod with a Tank Atomizer  
o Vape Mod with a Drip Atomizer  
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Q21 Which of the following reasons describe why you are using your electronic cigarette. (please select 
all that apply) 
 To avoid tobacco withdrawal symptoms, by using my electronic cigarette in areas where I 
am not allowed to smoke tobacco cigarettes  
 To quit smoking tobacco cigarettes, by reducing how many tobacco cigarettes I smoke  
 To quit smoking tobacco cigarettes, by replacing tobacco cigarettes with my electronic 
cigarette  
 To quit smoking tobacco cigarettes, by replacing tobacco cigarettes with my electronic 
cigarette and changing my nicotine level  
 To quit another form of tobacco  
 To control my appetite or for weight loss  
 I use my electronic cigarette for fun  
 I use my electronic cigarette for the buzz that nicotine gives me  
 Other, not listed here  
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Q22 Thinking about the previous question, which reason do you feel most closely describes why you use 
your electronic cigarette. (please select only one) 
o To avoid tobacco withdrawal symptoms, by using my electronic cigarette in areas where I am not 
allowed to smoke tobacco cigarettes  
o To quit smoking tobacco cigarettes, by reducing how many tobacco cigarettes I smoke  
o To quit smoking tobacco cigarettes, by replacing tobacco cigarettes with my electronic cigarette  
o To quit smoking tobacco cigarettes, by replacing tobacco cigarettes with my electronic cigarette 
and changing my nicotine level  
o To quit another form of tobacco  
o To control my appetite or for weight loss  
o I use my electronic cigarette for fun  
o I use my electronic cigarette for the buzz that nicotine gives me  
o Other, not listed here  
 
 
Display This Question: 
If Thinking about the previous question, which reason do you feel most closely describes why you use... = 
Other, not listed here 
Or Which of the following reasons describe why you are using your electronic cigarette. (please sele... = 
Other, not listed here 
 
Q23 You have selected other in one of the previous questions, please explain the reason why you use 
your electronic cigarette. 
________________________________________________________________ 
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Q24 Which of the following types of flavors do you use for your e-liquid? (please select all that apply) 
 Tobacco  
 Menthol  
 Fruit  
 Dessert  
 Candy  
 Beverage  
 Other  
 
 
 
 
Q25 Thinking about the above, which of the following types of flavors do you use most often for your e-
liquid? 
o Tobacco  
o Menthol  
o Fruit  
o Dessert  
o Candy  
o Beverage  
o Other  
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Display This Question: 
If Which of the following types of flavors do you use for your e-liquid? (please select all that apply) = Other 
Or Thinking about the above, which of the following types of flavors do you use most often for your... = Other 
 
Q26 You have selected other in one of the previous questions, please describe the flavor. 
________________________________________________________________ 
 
 
 
Q27 Have any of your friends or family members ever used an electronic cigarette? Please select one 
option for each of the following. 
 Yes No Uncertain/ Don't Know 
Immediate Family  o  o  o  
Other Family  o  o  o  
Close Friends  o  o  o  
Other Friends  o  o  o  
 
 
Skip To: Q30 If Have any of your friends or family members ever used an electronic cigarette? Please select one o... 
= Immediate Family 
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Q28 Do any of your friends or family members currently use electronic cigarettes? Please select one 
option for each of the following. 
 Yes No Uncertain/ Don't Know 
Immediate Family  o  o  o  
Other Family  o  o  o  
Close Friends  o  o  o  
Other Friends  o  o  o  
 
 
 
 
Q29 Have any of your friends or family members ever used their electronic cigarette to help them quit 
smoking tobacco cigarettes? Please select one option for each of the following. 
 Yes No Uncertain/ Don't Know 
Immediate Family  o  o  o  
Other Family  o  o  o  
Close Friends  o  o  o  
Other Friends  o  o  o  
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Q30  
What is your sex. 
o Female  
o Male  
 
 
 
Q31  
Are you Hispanic or Latino? 
o No  
o Yes, I am Hispanic or Latino/Latina  
 
 
 
Q32 What race or races do you consider yourself to be? (please select at least one, or all that apply) 
 American Indian or Alaska Native  
 Asian  
 Black or African American  
 Native Hawaiian or other Pacific Islander  
 White or Caucasian  
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Q33  
Please select the highest level of education you have completed. 
o Less than high school  
o High school graduate  
o Some college  
o 2-year degree (ex. Associate's degree)  
o 4-year degree (ex: Bachelor's degree)  
o Professional degree  
o Master's degree  
o Doctoral degree  
 
 
 
Q34 Have any of your friends or family members ever smoked tobacco cigarettes? Please select one 
option for each of the following. 
 Yes No Uncertain/ Don't Know 
Immediate Family  o  o  o  
Other Family  o  o  o  
Close Friends  o  o  o  
Other Friends  o  o  o  
 
 
Skip To: Q36 If Have any of your friends or family members ever smoked tobacco cigarettes? Please select one 
opt... = Immediate Family 
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Q35 Do any of your friends or family members currently smoke tobacco cigarettes? Please select one 
option for each of the following. 
 Yes No Uncertain/ Don't Know 
Immediate Family  o  o  o  
Other Family  o  o  o  
Close Friends  o  o  o  
Other Friends  o  o  o  
 
 
 
 
Q36 Have you ever smoked tobacco cigarettes? 
o Yes  
o No  
 
Skip To: Q48 If Have you ever smoked tobacco cigarettes? = No 
 
 
Q37 Have you smoked at least one (1) tobacco cigarette in the last month? 
o Yes  
o No  
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Q38 Have you smoked at least 100 tobacco cigarettes (5 packs) in your lifetime? 
o Yes  
o No  
 
 
 
 
Q39 How many years have you smoked tobacco cigarettes over your life? (years) 
________________________________________________________________ 
 
 
 
 
Q40 On average, how much do/did you spend on tobacco cigarettes over a month? (dollars and cents: 
00.00) 
________________________________________________________________ 
 
 
 
Q41 Do you now smoke tobacco cigarettes everyday, some days, or never? 
o Everyday  
o Some days  
o Never  
 
Skip To: Q44 If Do you now smoke tobacco cigarettes everyday, some days, or never? = Everyday 
 
 
 
Q42 When you smoked, how many tobacco cigarettes did you smoke in a day on average? (cigarettes) 
________________________________________________________________ 
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Q43 How many months has it been since you quit smoking tobacco cigarettes? (months) 
________________________________________________________________ 
 
Skip To: Q46 If How many months has it been since you quit smoking tobacco cigarettes? (months) Is Not Empty 
 
 
 
Q44 On average, how many tobacco cigarettes do you smoke each day? (cigarettes) 
________________________________________________________________ 
 
 
 
Q45 Are you trying to reduce how often you smoke tobacco cigarettes? 
o Yes  
o No  
 
 
 
 
Q46 In the past, about how many times have you tried to quit smoking tobacco cigarettes? (number of 
attempts) 
________________________________________________________________ 
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Q47  
Have you tried using any of the following methods to quit smoking tobacco cigarettes? (please  
select all that apply) 
 Nicotine Replacement Therapy (nicotine gum nicotine patches, or nicotine lozenges)  
 Chantix (varenicline tartrate)  
 Zyban (bupropion hydrochloride)  
 Cold turkey/ Willpower alone  
 Counseling/ Behavioral therapy  
 None of these  
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 Q48 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
Electronic 
cigarettes can 
be used to 
quit smoking 
tobacco 
cigarettes  
o  o  o  o  o  o  o  
Electronic 
cigarettes are 
safer than 
tobacco 
cigarettes  
o  o  o  o  o  o  o  
Electronic 
cigarettes are 
safe  o  o  o  o  o  o  o  
Electronic 
cigarettes are 
addictive  o  o  o  o  o  o  o  
Electronic 
cigarettes are 
socially 
accepted  
o  o  o  o  o  o  o  
Electronic 
cigarettes are 
safer than 
tobacco 
cigarettes 
around my 
friends and 
family  
o  o  o  o  o  o  o  
Electronic 
cigarettes are 
safer around 
my pets  
o  o  o  o  o  o  o  
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Q49 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
I can tell 
when I need 
to add more 
e-liquid to 
my 
electronic 
cigarette  
o  o  o  o  o  o  o  
I feel 
healthy 
using my 
electronic 
cigarette  
o  o  o  o  o  o  o  
I cough 
when using 
my 
electronic 
cigarette  
o  o  o  o  o  o  o  
I cough 
more using 
tobacco 
cigarettes 
than 
electronic 
cigarettes  
o  o  o  o  o  o  o  
I get 
headaches 
when using 
my 
electronic 
cigarette  
o  o  o  o  o  o  o  
My throat 
gets 
sore/dry 
when I use 
my 
electronic 
cigarette  
o  o  o  o  o  o  o  
I am able to 
taper down 
my nicotine 
level over 
time  
o  o  o  o  o  o  o  
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Q50 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree 
nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
I am 
saving 
money 
with my 
electronic 
cigarette  
o  o o  o  o  o  o  
I want to 
stop using 
my 
electronic 
cigarette  
o  o o  o  o  o  o  
I want to 
quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
I believe I 
can quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
I believe I 
can stop 
using my 
electronic 
cigarette  
o  o o  o  o  o  o  
I believe 
my 
electronic 
cigarette 
will help 
me quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
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Q51 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree 
nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
I crave 
using my 
electronic 
cigarette  
o  o o  o  o  o  o  
I crave 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
I don't want 
to stop 
using my 
electronic 
cigarette  
o  o o  o  o  o  o  
I don't want 
to quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
I am 
addicted to 
my 
electronic 
cigarette  
o  o o  o  o  o  o  
I can't leave 
my house 
without my 
electronic 
cigarette  
o  o o  o  o  o  o  
I have to 
use my 
electronic 
cigarette at 
work/school  
o  o o  o  o  o  o  
Electronic 
cigarettes 
can be used 
in more 
places than 
tobacco 
cigarettes  
o  o o  o  o  o  o  
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Q52 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree 
nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
My family 
wants me 
to quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
My family 
is 
supportive 
of me 
quitting 
tobacco 
cigarettes  
o  o o  o  o  o  o  
My 
friends 
want me 
to quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
My 
friends are 
supportive 
of me 
quitting 
tobacco 
cigarettes  
o  o o  o  o  o  o  
E-liquid 
flavors 
help me to 
quit 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
E-liquid 
flavors 
help me to 
not crave 
smoking 
tobacco 
cigarettes  
o  o o  o  o  o  o  
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Q53 Please identify your level of agreement for each of the following statements. (Strongly agree to 
Strongly disagree) 
 Strongly agree Agree 
Somewhat 
agree 
Neither 
agree 
nor 
disagree 
Somewhat 
disagree Disagree 
Strongly 
disagree 
My friends and 
family encourage 
me to use my 
electronic 
cigarette  
o  o o  o  o  o  o  
My family wants 
me to stop using 
my electronic 
cigarette  
o  o o  o  o  o  o  
My friends want 
me to stop using 
my electronic 
cigarette  
o  o o  o  o  o  o  
My 
coworkers/fellow 
students don't 
mind me using 
my electronic 
cigarette  
o  o o  o  o  o  o  
I think my 
friends approve 
of me using my 
electronic 
cigarette  
o  o o  o  o  o  o  
I think my 
family approves 
of me using my 
electronic 
cigarette  
o  o o  o  o  o  o  
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Q54  
Thank you for completing this survey. Your participation is greatly appreciated.   
Your Amazon e-gift card will be emailed to you within the next 10 business days.   
Please note that you will receive the next survey via email in 6 months. 
 
 
Display This Question: 
If  Thank you for completing this survey. Your participation is greatly appreciated. Your Amazon e-gi... Is Not 
Displayed 
 
Q55 Thank you for your time but you have not qualified to complete this survey. 
End of Block: E-Cigarette Survey 
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VITA 
 Born in 1992, David D. Allen III has had a wide variety of experiences during his 
upbringing. While born in Kentucky, he was raised primarily in the Panhandle of Texas and 
northeast Ohio. David has been exposed to a plethora of lifestyles in different settings throughout 
his lifetime, seeing the ups and downs of individual and societal issues. This Thesis focused on 
something close to his passion, to enable individuals to reach nicotine cessation through their 
own means and hopefully prevent the known adverse events associated with tobacco use. 
David completed his Bachelor’s in Political Science at the University of North Texas in 
Denton, Texas. After a break year, he began the pursuit of his Master’s and PhD in 
Pharmaceutical Sciences with an emphasis in Pharmacy Administration. His experiences in 
healthcare policy, public health, and pharmacoeconomics enabled him to bring this Master’s 
Thesis to light under the guidance of a body of supportive faculty members and fellow student 
colleagues. 
 David has been associated with a small amount of publications at this time but aims to 
grow his peer-reviewed repertoire after the dissemination of this Thesis publication. His 
maintains his interest in research looking at potentially harm reducing strategies to aid in the 
cessation of various substances, including nicotine. In doing so, he hopes to further this research 
moving forward into the development, enactment, and future dissemination of his Doctoral 
Dissertation. 
